Systems Pharmacology for Investigation of the Mechanisms of Action of Traditional Chinese Medicine in Drug Discovery
暂无分享,去创建一个
Airong Qian | Wenjuan Zhang | Yonghua Wang | Ying Huai | Zhiping Miao | Yonghua Wang | A. Qian | Zhiping Miao | Wenjuan Zhang | Ying Huai
[1] Yan Li,et al. A systematic identification of multiple toxin-target interactions based on chemical, genomic and toxicological data. , 2013, Toxicology.
[2] Yonghua Wang,et al. Systems Pharmacology Uncovers the Multiple Mechanisms of Xijiao Dihuang Decoction for the Treatment of Viral Hemorrhagic Fever , 2016, Evidence-based complementary and alternative medicine : eCAM.
[3] David S. Wishart,et al. DrugBank 3.0: a comprehensive resource for ‘Omics’ research on drugs , 2010, Nucleic Acids Res..
[4] A. Hopkins. Network pharmacology: the next paradigm in drug discovery. , 2008, Nature chemical biology.
[5] A. Hopkins. Network pharmacology , 2007, Nature Biotechnology.
[6] Yan Li,et al. Insight into the effects of chiral isomers quinidine and quinine on CYP2D6 inhibition. , 2009, Bioorganic & medicinal chemistry letters.
[7] Yoshihiro Yamanishi,et al. Extracting Sets of Chemical Substructures and Protein Domains Governing Drug-Target Interactions , 2011, J. Chem. Inf. Model..
[8] Zhaolei Zhang,et al. Alternative signaling pathways: When, where and why? , 2005, FEBS letters.
[9] J. Lehár,et al. Synergistic drug combinations improve therapeutic selectivity , 2009, Nature Biotechnology.
[10] S. Ventegodt,,et al. Holistic Medicine: Scientific Challenges , 2003, TheScientificWorldJournal.
[11] T. Baillie,et al. Organic Chemistry in Drug Discovery , 2004, Science.
[12] Jing Fan,et al. Traditional Chinese medicine: potential approaches from modern dynamical complexity theories , 2016, Frontiers of Medicine.
[13] Dexi Liu,et al. Cationic transfection lipids. , 2003, Current medicinal chemistry.
[14] Hao Ye,et al. HIT: linking herbal active ingredients to targets , 2010, Nucleic Acids Res..
[15] Xiaomin Luo,et al. Estimation of elimination half-lives of organic chemicals in humans using gradient boosting machine. , 2016, Biochimica et biophysica acta.
[16] Xin Wen,et al. BindingDB: a web-accessible database of experimentally determined protein–ligand binding affinities , 2006, Nucleic Acids Res..
[17] A. Wang,et al. [Evaluation of shensongyangxin capsules in the treatment of paroxysmal atrial fibrillation: a randomized, double-blind and controlled multicenter trial]. , 2011, Zhonghua yi xue za zhi.
[18] K. Chou,et al. Predicting Drug-Target Interaction Networks Based on Functional Groups and Biological Features , 2010, PloS one.
[19] Xue Xu,et al. A Systems Biology Approach to Uncovering Pharmacological Synergy in Herbal Medicines with Applications to Cardiovascular Disease , 2012, Evidence-based complementary and alternative medicine : eCAM.
[20] Yonghua Wang,et al. Systematic Investigation of Ginkgo Biloba Leaves for Treating Cardio-cerebrovascular Diseases in an Animal Model. , 2017, ACS chemical biology.
[21] Wei Li,et al. Investigation of binding features: Effects on the interaction between CYP2A6 and inhibitors , 2010, J. Comput. Chem..
[22] Peng Jiang,et al. Molecular networks for the study of TCM Pharmacology , 2010, Briefings Bioinform..
[23] Konstantin V. Balakin,et al. Property-Based Design of GPCR-Targeted Library , 2002, J. Chem. Inf. Comput. Sci..
[24] Ajay N. Jain. Surflex: fully automatic flexible molecular docking using a molecular similarity-based search engine. , 2003, Journal of medicinal chemistry.
[25] Yonghua Wang,et al. Deciphering the combination principles of Traditional Chinese Medicine from a systems pharmacology perspective based on Ma-huang Decoction. , 2013, Journal of ethnopharmacology.
[26] Yonghua Wang,et al. A Systems-Pharmacology Analysis of Herbal Medicines Used in Health Improvement Treatment: Predicting Potential New Drugs and Targets , 2013, Evidence-based complementary and alternative medicine : eCAM.
[27] Xiaojie Xu,et al. CVDHD: a cardiovascular disease herbal database for drug discovery and network pharmacology , 2013, Journal of Cheminformatics.
[28] Peter J. Park,et al. Systematic Identification of Synergistic Drug Pairs Targeting HIV , 2012, Nature Biotechnology.
[29] A. Urtti,et al. Prediction of the Vitreal Half-Life of Small Molecular Drug-Like Compounds , 2012, Pharmaceutical Research.
[30] J. Topliss,et al. QSAR model for drug human oral bioavailability. , 2000, Journal of medicinal chemistry.
[31] Donald Morrill. Of Systems , 2009 .
[32] Wei Zhang,et al. ETCM: an encyclopaedia of traditional Chinese medicine , 2018, Nucleic Acids Res..
[33] Yonghua Wang,et al. Systematic understanding the mechanisms of vitiligo pathogenesis and its treatment by Qubaibabuqi formula. , 2016, Journal of ethnopharmacology.
[34] Calvin Yu-Chian Chen,et al. TCM Database@Taiwan: The World's Largest Traditional Chinese Medicine Database for Drug Screening In Silico , 2011, PloS one.
[35] Yan Li,et al. A classification study of human β3-adrenergic receptor agonists using BCUT descriptors , 2011, Molecular Diversity.
[36] Influence of P-glycoprotein on embryotoxicity of the antifouling biocides to sea urchin (Strongylocentrotus intermedius) , 2011, Ecotoxicology.
[37] Shao Li,et al. Network Systems Underlying Traditional Chinese Medicine Syndrome and Herb Formula , 2009 .
[38] Bo Chen,et al. Sample preparation for analyzing traditional Chinese medicines , 2009 .
[39] Jianxin Chen,et al. Large-scale exploration and analysis of drug combinations , 2015, Bioinform..
[40] Wei Xiao,et al. Weak-binding molecules are not drugs?—toward a systematic strategy for finding effective weak-binding drugs , 2016, Briefings Bioinform..
[41] John G. Topliss,et al. QSAR Model for Drug Human Oral Bioavailability1 , 2000 .
[42] Yonghua Wang,et al. Systems Pharmacology Dissecting Holistic Medicine for Treatment of Complex Diseases: An Example Using Cardiocerebrovascular Diseases Treated by TCM , 2015, Evidence-based complementary and alternative medicine : eCAM.
[43] Lawrence X. Yu. An Integrated Model for Determining Causes of Poor Oral Drug Absorption , 1999, Pharmaceutical Research.
[44] Xue Xu,et al. A System-Level Investigation into the Mechanisms of Chinese Traditional Medicine: Compound Danshen Formula for Cardiovascular Disease Treatment , 2012, PloS one.
[45] T. Klabunde. Chemogenomic approaches to drug discovery: similar receptors bind similar ligands , 2007, British journal of pharmacology.
[46] Yuan Wang,et al. CancerHSP: anticancer herbs database of systems pharmacology , 2015, Scientific Reports.
[47] Yue Weng,et al. Structure of P-Glycoprotein Reveals a Molecular Basis for Poly-Specific Drug Binding , 2009, Science.
[48] Konstantin V. Balakin,et al. Property-Based Design of GPCR-Targeted Library. , 2003 .
[49] Jon A Arnot,et al. Estimating screening-level organic chemical half-lives in humans. , 2014, Environmental science & technology.
[50] Hua Yu,et al. A Systematic Prediction of Multiple Drug-Target Interactions from Chemical, Genomic, and Pharmacological Data , 2012, PloS one.
[51] Xing-Ming Zhao,et al. Prediction of Drug Combinations by Integrating Molecular and Pharmacological Data , 2011, PLoS Comput. Biol..
[52] Evi Kostenis,et al. A physicogenetic method to assign ligand-binding relationships between 7TM receptors. , 2005, Bioorganic & medicinal chemistry letters.
[53] Liang Sun,et al. SymMap: an integrative database of traditional Chinese medicine enhanced by symptom mapping , 2018, Nucleic Acids Res..
[54] L. Berezhkovskiy. Prediction of drug terminal half-life and terminal volume of distribution after intravenous dosing based on drug clearance, steady-state volume of distribution, and physiological parameters of the body. , 2013, Journal of pharmaceutical sciences.
[55] Wei Zhou,et al. A novel systems pharmacology model for herbal medicine injection: a case using reduning injection , 2014, BMC Complementary and Alternative Medicine.
[56] Bin Chen,et al. PubChem as a Source of Polypharmacology , 2009, J. Chem. Inf. Model..
[57] Wei Zhou,et al. A network-based analysis of the types of coronary artery disease from traditional Chinese medicine perspective: potential for therapeutics and drug discovery. , 2014, Journal of ethnopharmacology.
[58] Roger J. Davis,et al. TNF and MAP kinase signalling pathways. , 2014, Seminars in immunology.
[59] Dragos Horvath,et al. Predicting ADME properties and side effects: the BioPrint approach. , 2003, Current opinion in drug discovery & development.
[60] David W. Ritchie,et al. GES Polypharmacology Fingerprints: A Novel Approach for Drug Repositioning , 2014, J. Chem. Inf. Model..
[61] Wei Zhou,et al. TCMSP: a database of systems pharmacology for drug discovery from herbal medicines , 2014, Journal of Cheminformatics.
[62] Chao Huang,et al. Systems pharmacology in drug discovery and therapeutic insight for herbal medicines , 2014, Briefings Bioinform..
[63] T. Chou. Drug combination studies and their synergy quantification using the Chou-Talalay method. , 2010, Cancer research.
[64] Ling-Yun Wu,et al. Semi-supervised Drug-Protein Interaction Prediction from Heterogeneous Spaces , 2009 .
[65] R. Cahn. Techniques of extraction , 1996, Nature.
[66] Gajendra P. S. Raghava,et al. CancerPPD: a database of anticancer peptides and proteins , 2014, Nucleic Acids Res..
[67] Yonghua Wang,et al. A Systems Biology Approach to Understanding the Mechanisms of Action of Chinese Herbs for Treatment of Cardiovascular Disease , 2012, International journal of molecular sciences.
[68] Li-ping Yang,et al. Application of systems biology technology in research of traditional Chinese medicine. , 2009, Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan.
[69] F. Lombardo,et al. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings , 1997 .
[70] Tao Xu,et al. Target Inhibition Networks: Predicting Selective Combinations of Druggable Targets to Block Cancer Survival Pathways , 2013, PLoS Comput. Biol..
[71] A. Boulesteix. PLS Dimension Reduction for Classification with Microarray Data , 2004, Statistical applications in genetics and molecular biology.
[72] Yan Li,et al. Systems Pharmacology Dissection of Multiscale Mechanisms of Action for Herbal Medicines in Treating Rheumatoid Arthritis. , 2017, Molecular pharmaceutics.
[73] Tingjun Hou,et al. ADME evaluation in drug discovery , 2002, Journal of molecular modeling.
[74] Y. Z. Chen,et al. Database of traditional Chinese medicine and its application to studies of mechanism and to prescription validation , 2006, British journal of pharmacology.
[75] B Agoram,et al. Predicting the impact of physiological and biochemical processes on oral drug bioavailability. , 2001, Advanced drug delivery reviews.
[76] B. Roth,et al. The Multiplicity of Serotonin Receptors: Uselessly Diverse Molecules or an Embarrassment of Riches? , 2000 .
[77] Yoshihiro Yamanishi,et al. Drug-target interaction prediction from chemical, genomic and pharmacological data in an integrated framework , 2010, Bioinform..
[78] Yan Li,et al. Large-scale Direct Targeting for Drug Repositioning and Discovery , 2015, Scientific Reports.
[79] Lik Tong Tan,et al. Bioactive natural products from marine cyanobacteria for drug discovery. , 2007, Phytochemistry.
[80] F. Lombardo,et al. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. , 2001, Advanced drug delivery reviews.
[81] Esa Alhoniemi,et al. Clustering of the self-organizing map , 2000, IEEE Trans. Neural Networks Learn. Syst..
[82] Lin He,et al. Prediction of Drug-Target Interactions for Drug Repositioning Only Based on Genomic Expression Similarity , 2013, PLoS Comput. Biol..
[83] Susan E. Abbatiello,et al. Erratum: Synergistic drug combinations tend to improve therapeutically relevant selectivity , 2009, Nature Biotechnology.
[84] Hai Pham-The,et al. Computational modeling of human oral bioavailability: what will be next? , 2018, Expert opinion on drug discovery.
[85] Rahul Kumar,et al. CancerDR: Cancer Drug Resistance Database , 2013, Scientific Reports.
[86] Yonghua Wang,et al. Systems pharmacology-based dissection of mechanisms of Chinese medicinal formula Bufei Yishen as an effective treatment for chronic obstructive pulmonary disease , 2015, Scientific Reports.
[87] G. Parmigiani,et al. Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses , 2008, Science.
[88] Snezana Agatonovic-Kustrin,et al. Multiple pharmacokinetic parameter prediction for a series of cephalosporins. , 2003, Journal of pharmaceutical sciences.
[89] Arun Sharma,et al. Designing of peptides with desired half-life in intestine-like environment , 2014, BMC Bioinformatics.
[90] Zhenzhong Wang,et al. Systems Pharmacology Dissection of the Integrated Treatment for Cardiovascular and Gastrointestinal Disorders by Traditional Chinese Medicine , 2016, Scientific Reports.
[91] J. Ballesteros,et al. G protein-coupled receptor drug discovery: implications from the crystal structure of rhodopsin. , 2001, Current opinion in drug discovery & development.
[92] Xiaojie Xu,et al. 1. Applications of genetic algorithms to the prediction of blood-brain partitioning of a large set of drugs , 2002 .
[93] Yasubumi Sakakibara,et al. Statistical prediction of protein-chemical interactions based on chemical structure and mass spectrometry data , 2007, Bioinform..
[94] Yonghua Wang,et al. Understanding the Aquatic Toxicity of Pesticide: Structure‐Activity Relationship and Molecular Descriptors to Distinguish the Ratings of Toxicity , 2009 .
[95] J. Pu,et al. Chinese Medicine Shensongyangxin Is Effective for Patients with Bradycardia: Results of a Randomized, Double-Blind, Placebo-Controlled Multicenter Trial , 2014, Evidence-based complementary and alternative medicine : eCAM.
[96] Jing Hu,et al. Establishing an evaluation mode with multiple primary outcomes based on combination of diseases and symptoms in TCM clinical trials. , 2017, Annals of translational medicine.
[97] Wen-Jian Wang,et al. Integration of traditional Chinese medicine and Western medicine in the era of precision medicine. , 2017, Journal of integrative medicine.
[98] Xiaojie Xu,et al. Selective separation of active inhibitors of epidermal growth factor receptor from Caragana jubata by molecularly imprinted solid-phase extraction. , 2003, Journal of chromatography. A.
[99] Zhao Fang,et al. TCMID: traditional Chinese medicine integrative database for herb molecular mechanism analysis , 2012, Nucleic Acids Res..
[100] D. Rognan. Chemogenomic approaches to rational drug design , 2007, British journal of pharmacology.
[101] Thomas M. Ehrman,et al. Phytochemical Databases of Chinese Herbal Constituents and Bioactive Plant Compounds with Known Target Specificities. , 2007 .
[102] Yonghua Wang,et al. Pred-binding: large-scale protein–ligand binding affinity prediction , 2016, Journal of enzyme inhibition and medicinal chemistry.
[103] F. Cheng,et al. Systems Pharmacology‐Based Discovery of Natural Products for Precision Oncology Through Targeting Cancer Mutated Genes , 2017, CPT: pharmacometrics & systems pharmacology.
[104] Qing-Wen Zhang,et al. Techniques for extraction and isolation of natural products: a comprehensive review , 2018, Chinese Medicine.
[105] Peng Li,et al. Insights from systems pharmacology into cardiovascular drug discovery and therapy , 2014, BMC Systems Biology.
[106] Hua Yu,et al. A Novel Chemometric Method for the Prediction of Human Oral Bioavailability , 2012, International journal of molecular sciences.
[107] Charles Boone,et al. Systems-level antimicrobial drug and drug synergy discovery. , 2013, Nature chemical biology.
[108] J. Lehár,et al. Multi-target therapeutics: when the whole is greater than the sum of the parts. , 2007, Drug discovery today.
[109] G. Johnson,et al. Mitogen-Activated Protein Kinase Pathways Mediated by ERK, JNK, and p38 Protein Kinases , 2002, Science.
[110] Chenchen Wang,et al. Traditional Chinese Medications for Knee Osteoarthritis Pain: A Meta-Analysis of Randomized Controlled Trials. , 2016, The American journal of Chinese medicine.
[111] Mingliang Ye,et al. Biological fingerprinting analysis of traditional Chinese medicines with targeting ADME/Tox property for screening of bioactive compounds by chromatographic and MS methods. , 2007, Mini reviews in medicinal chemistry.
[112] Dong-Sheng Cao,et al. Large-scale prediction of drug-target interactions using protein sequences and drug topological structures. , 2012, Analytica chimica acta.
[113] Jens Sadowski,et al. Comparison of Support Vector Machine and Artificial Neural Network Systems for Drug/Nondrug Classification , 2003, J. Chem. Inf. Comput. Sci..
[114] B. Al-Lazikani,et al. Combinatorial drug therapy for cancer in the post-genomic era , 2012, Nature Biotechnology.
[115] Aiping Lu,et al. Syndrome differentiation in modern research of traditional Chinese medicine. , 2012, Journal of ethnopharmacology.
[116] Oliver Werz,et al. Hyperforin is a dual inhibitor of cyclooxygenase-1 and 5-lipoxygenase. , 2002, Biochemical pharmacology.
[117] Jinan Wang,et al. Systems approaches and polypharmacology for drug discovery from herbal medicines: an example using licorice. , 2013, Journal of ethnopharmacology.
[118] Xue Xu,et al. Assessment of toxic interactions of heavy metals in multi-component mixtures using sea urchin embryo-larval bioassay. , 2011, Toxicology in vitro : an international journal published in association with BIBRA.
[119] Yuanping Wang,et al. Chinese herbal medicine for patients with atrial fibrillation: protocol for a systematic review and meta-analysis , 2017, Medicine.
[120] G Fisch,et al. Traditional chinese medicine , 2015, Reactions Weekly.
[121] J. Lehár,et al. Systematic discovery of multicomponent therapeutics , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[122] D. Kassel,et al. Applications of high-throughput ADME in drug discovery. , 2004, Current opinion in chemical biology.